Αποτελέσματα Αναζήτησης
Malignant ascites indicates the presence of malignant cells in the peritoneal cavity and is a grave prognostic sign. While survival in this patient population is poor, averaging about 20 wk from time of diagnosis, quality of life can be improved through palliative procedures.
Our findings also demonstrated that female gender is associated with longer survival and better prognosis in malignant ascites and we believe that this is due to the combined preponderance of ovarian and breast cancer groups.
Ascites (uh-SIGH-tees) refers to excess fluid in the abdomen. This fluid collects in the space within the walls of the abdomen, between the abdominal organs. It is common in patients with liver disease and cirrhosis, though patients with cancer can also develop ascites.
12 Σεπ 2023 · Paramalignant ascites is the formation of ascites in patients with cancer without the cytologic proof of tumor cells. This condition may be caused by cancer-related comorbidities such as liver cirrhosis, portal vein obstruction, heart failure, pancreatitis or infections.
Malignant ascites affects a significant proportion of women with advanced and recurrent ovarian cancer. It frequently becomes the most pertinent issue in these patients and can have a detrimental effect on their QOL.
The underlying malignancy, its symptoms, and prognosis are important to direct clinical decision making in MA drainage. The life expectancy of patients with refractory MA is very poor, with an overall survival ranging from 1 to 6 months in nonovarian cancer and 10–24 months in ovarian cancer.
25 Μαΐ 2020 · The median survival following diagnosis of ascites was three months. Ovarian cancer favored longer survival while low serum albumin, low serum protein and liver metastases adversely affected survival. The independent prognostic factors for survival were cancer type, liver metastases and serum albumin.
